<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39392813</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>10</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Spectrum of COVID-19 cases in Arkhangelsk, Northwest Russia: Findings from a population-based study linking serosurvey, registry data, and self-reports of symptoms.</ArticleTitle><Pagination><StartPage>e0311287</StartPage><MedlinePgn>e0311287</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0311287</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0311287</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The spectrum of COVID-19 manifestations makes it challenging to estimate the exact proportion of people who had the infection in a population, with the proportion of asymptomatic cases likely being underestimated. We aimed to assess and describe the spectrum of COVID-19 cases in a sample of adult population aged 40-74 years in Arkhangelsk, Northwest Russia, a year after the start of the pandemic.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">A population-based survey conducted between February 24, 2021 and June 30, 2021 with an unvaccinated sample aged 40-74 years (N = 1089) combined a serological survey data, national COVID-19 case registry, and self-reported data on COVID-19 experience and symptoms. Based on the agreement between these sources, we classified the study participants as non-infected and previously infected (asymptomatic, non-hospitalized and hospitalized symptomatic) cases, and compared these groups regarding demographics, lifestyle and health characteristics.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">After a year of the pandemic in Arkhangelsk, 59.7% 95% confidence intervals (CI) (56.7; 62.6) of the surveyed population had had COVID-19. Among those who had been infected, symptomatic cases comprised 47.1% 95% CI (43.2; 51.0), with 8.6% 95% CI (6.6; 11.1) of them having been hospitalized. Of the asymptomatic cases, 96.2% were not captured by the healthcare system. Older age was positively associated, while smoking showed a negative association with symptomatic COVID-19. Individuals older than 65 years, and those with poor self-rated health were more likely to be hospitalized.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">More than half of the infected individuals were not captured by the healthcare-based registry, mainly those with asymptomatic infections. COVID-19 severity was positively associated with older age and poor self-rated health, and inversely associated with smoking. Combining different sources of surveillance data could reduce the number of unidentified asymptomatic cases and enhance surveillance for emerging infections.</AbstractText><CopyrightInformation>Copyright: © 2024 Krieger et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Krieger</LastName><ForeName>Ekaterina</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-5179-5737</Identifier><AffiliationInfo><Affiliation>Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Research Competence Centre, Northern State Medical University, Arkhangelsk, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kudryavtsev</LastName><ForeName>Alexander V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>International Research Competence Centre, Northern State Medical University, Arkhangelsk, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharashova</LastName><ForeName>Ekaterina</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-9412-2065</Identifier><AffiliationInfo><Affiliation>Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samodova</LastName><ForeName>Olga</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Infectious diseases, Northern State Medical University, Arkhangelsk, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kontsevaya</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Public Health, National Medical Research Centre for Therapy and Preventive Medicine, Moscow, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Postoev</LastName><ForeName>Vitaly A</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>Department of Research Methodology, Northern State Medical University, Arkhangelsk, Russian Federation.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012426" MajorTopicYN="N" Type="Geographic">Russia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="Y">Self Report</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="Y">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>the authors report there are no competing interests to declare</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>18</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>18</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>13</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39392813</ArticleId><ArticleId IdType="pmc">PMC11469529</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0311287</ArticleId><ArticleId IdType="pii">PONE-D-23-20691</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zeng H, Ma Y, Zhou Z, Liu W, Huang P, Jiang M, et al.. Spectrum and Clinical Characteristics of Symptomatic and Asymptomatic Coronavirus Disease 2019 (COVID-19) With and Without Pneumonia. Front Med. 2021;8:645–651. doi: 10.3389/fmed.2021.645651</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.645651</ArticleId><ArticleId IdType="pmc">PMC8046922</ArticleId><ArticleId IdType="pubmed">33869253</ArticleId></ArticleIdList></Reference><Reference><Citation>Çelik I, Öztürk R. From asymptomatic to critical illness: decoding various clinical stages of COVID-19. Turk J Med Sci. 2021;51(Si-1):3284–3300. doi: 10.3906/sag-2107-137</Citation><ArticleIdList><ArticleId IdType="doi">10.3906/sag-2107-137</ArticleId><ArticleId IdType="pmc">PMC8771010</ArticleId><ArticleId IdType="pubmed">34445855</ArticleId></ArticleIdList></Reference><Reference><Citation>Pijls BG, Jolani S, Atherley A, Derckx RT, Dijkstra JIR, Franssen GHL, et al.. Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies. BMJ open. 2021;11(1):e044640. doi: 10.1136/bmjopen-2020-044640</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-044640</ArticleId><ArticleId IdType="pmc">PMC7802392</ArticleId><ArticleId IdType="pubmed">33431495</ArticleId></ArticleIdList></Reference><Reference><Citation>Sannigrahi S, Pilla F, Basu B, Basu AS, Molter A. Examining the association between socio-demographic composition and COVID-19 fatalities in the European region using spatial regression approach. Sustain Cities Soc. 2020;62:102418. doi: 10.1016/j.scs.2020.102418</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scs.2020.102418</ArticleId><ArticleId IdType="pmc">PMC7395296</ArticleId><ArticleId IdType="pubmed">32834939</ArticleId></ArticleIdList></Reference><Reference><Citation>Shubin M., Virtanen M., Toikkanen S., Lyytikäinen O., &amp; Auranen K. Estimating the burden of A(H1N1)pdm09 influenza in Finland during two seasons. Epidemiol Infect. 2014; 142(5): 964–974. doi: 10.1017/S0950268813002537</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268813002537</ArticleId><ArticleId IdType="pmc">PMC4097990</ArticleId><ArticleId IdType="pubmed">24139316</ArticleId></ArticleIdList></Reference><Reference><Citation>Balmford B, Annan JD, Hargreaves JC, Altoè M, Bateman IJ. Cross-Country Comparisons of Covid-19: Policy, Politics and the Price of Life. ERE. 2020;76(4):525–551. doi: 10.1007/s10640-020-00466-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10640-020-00466-5</ArticleId><ArticleId IdType="pmc">PMC7400753</ArticleId><ArticleId IdType="pubmed">32836862</ArticleId></ArticleIdList></Reference><Reference><Citation>Decree of the Russian President of March 25, 2020. No. 206 “On the establishment of non-working days in the territory of the Russian Federation.” Moscow.</Citation></Reference><Reference><Citation>Decree of the Russian President of April 2, 2020. No. 239 “On measures for ensuring sanitary and epidemiologic wellbeing of the population in the territory of the Russian Federation in connection with spread of new coronavirus infection (COVID-19).” Moscow.</Citation></Reference><Reference><Citation>Decree of the Russian President of April 28, 2020. No. 294. “On the extension of measures to ensure the sanitary and epidemiologic wellbeing of the population in the territory of the Russian Federation in connection with spread of new coronavirus infection (COVID-19).” Moscow.</Citation></Reference><Reference><Citation>Decree of the Russian President of May 11, 2020. No. 316. “On definition of the procedure for prolongation of measures to ensure sanitary-epidemiological well-being of the population in the subjects of the Russian Federation in connection with the spread of new coronavirus infection (COVID-19)” Moscow.</Citation></Reference><Reference><Citation>Methodological Recommendations MP 3.1.0178–20 “Definition of a Set of Measures, as Well as Indicators That Are the Basis for the Phased Removal of Restrictive Measures in the Conditions of the Epidemic Spread of COVID-19”.</Citation></Reference><Reference><Citation>Krantz SG, Rao A. Level of underreporting including underdiagnosis before the first peak of COVID-19 in various countries: Preliminary retrospective results based on wavelets and deterministic modeling. ICHE. 2020;41(7):857–859. doi: 10.1017/ice.2020.116</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2020.116</ArticleId><ArticleId IdType="pmc">PMC7170968</ArticleId><ArticleId IdType="pubmed">32268929</ArticleId></ArticleIdList></Reference><Reference><Citation>Public health surveillance for COVID-19. Interim guidance. [cited 2023 May 31]. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-SurveillanceGuidance-2022.2</Citation></Reference><Reference><Citation>Sah P, Fitzpatrick MC, Zimmer CF, Abdollahi E, Juden-Kelly L, Moghadas SM, et al.. Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis. Proc Natl Acad Sci U S A. 2021;118(34). doi: 10.1073/pnas.2109229118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2109229118</ArticleId><ArticleId IdType="pmc">PMC8403749</ArticleId><ArticleId IdType="pubmed">34376550</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al.. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med. 2020;382(12):1177–1179. doi: 10.1056/NEJMc2001737</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2001737</ArticleId><ArticleId IdType="pmc">PMC7121626</ArticleId><ArticleId IdType="pubmed">32074444</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuster AC, Overgaard HJ. A novel comprehensive metric to assess effectiveness of COVID-19 testing: Inter-country comparison and association with geography, government, and policy response. PloS one. 2021;16(3):e0248176. doi: 10.1371/journal.pone.0248176</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0248176</ArticleId><ArticleId IdType="pmc">PMC7935311</ArticleId><ArticleId IdType="pubmed">33667280</ArticleId></ArticleIdList></Reference><Reference><Citation>Decree of the Russian Government №373 of March 31, 2020. “About approval of Provisional rules of accounting of information for the purpose of prevention of spread of new coronavirus infection (COVID-19)”.</Citation></Reference><Reference><Citation>Clark-Boucher D, Boss J, Salvatore M, Smith JA, Fritsche LG, Mukherjee B. Assessing the added value of linking electronic health records to improve the prediction of self-reported COVID-19 testing and diagnosis. PloS one. 2022;17(7):e0269017. doi: 10.1371/journal.pone.0269017</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0269017</ArticleId><ArticleId IdType="pmc">PMC9312965</ArticleId><ArticleId IdType="pubmed">35877617</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O, Dobler CC, Bell K, Rojas DP, Clark J, McLaws ML, et al.. Comparison of seroprevalence of SARS-CoV-2 infections with cumulative and imputed COVID-19 cases: Systematic review. PloS one. 2021;16(4):e0248946. doi: 10.1371/journal.pone.0248946</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0248946</ArticleId><ArticleId IdType="pmc">PMC8018669</ArticleId><ArticleId IdType="pubmed">33798211</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevention, diagnosis and treatment of new coronavirus infection (COVID-19): temporal methodological recommendations of the Ministry of health of Russian Federation. Version 3–5. Moscow: The Ministry of Health of Russian Federation; 2021.</Citation></Reference><Reference><Citation>Böger B, Fachi MM, Vilhena RO, Cobre AF, Tonin FS, Pontarolo R. Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19. Am J Infect Control. 2021;49(1):21–29. doi: 10.1016/j.ajic.2020.07.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajic.2020.07.011</ArticleId><ArticleId IdType="pmc">PMC7350782</ArticleId><ArticleId IdType="pubmed">32659413</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucirka LM, Lauer SA, Laeyendecker O, Boon D, Lessler J. Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure. Annals of internal medicine. 2020;173(4):262–7. doi: 10.7326/M20-1495</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-1495</ArticleId><ArticleId IdType="pmc">PMC7240870</ArticleId><ArticleId IdType="pubmed">32422057</ArticleId></ArticleIdList></Reference><Reference><Citation>Krajewski R, Gołębiowska J, Makuch S, Mazur G, Agrawal S. Update on serologic testing in COVID-19. Clinica Chim Acta. 2020;510:746–50. doi: 10.1016/j.cca.2020.09.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2020.09.015</ArticleId><ArticleId IdType="pmc">PMC7491380</ArticleId><ArticleId IdType="pubmed">32946795</ArticleId></ArticleIdList></Reference><Reference><Citation>Krieger E, Sharashova E, Kudryavtsev AV, Samodova O, Kontsevaya A, Brenn T, et al.. COVID-19: seroprevalence and adherence to preventive measures in Arkhangelsk, Northwest Russia. Infect dis (Lond). 2023;55(5):316–327. doi: 10.1080/23744235.2023.2179660</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2023.2179660</ArticleId><ArticleId IdType="pubmed">36919829</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook S, Malyutina S, Kudryavtsev AV, Averina M, Bobrova N, Boytsov S, et al.. Know Your Heart: Rationale, design and conduct of a cross-sectional study of cardiovascular structure, function and risk factors in 4500 men and women aged 35–69 years from two Russian cities, 2015–18. Wellcome Open Res. 2018;3:67. doi: 10.12688/wellcomeopenres.14619.3</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/wellcomeopenres.14619.3</ArticleId><ArticleId IdType="pmc">PMC6073094</ArticleId><ArticleId IdType="pubmed">30123849</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. Alcohol, heavy episodic drinking (15þ) past 30 days (%), age-standardized with 95%CI; 2021. Available from: https://wwwwhoint/data/gho/data/indicators/indicatordetails/GHO/alcohol-heavy-episodic-drinking-(15-)-past-30-days-(-)-age-standardized-with-95-ci.</Citation></Reference><Reference><Citation>Barchuk A, Shirokov D, Sergeeva M, Tursun Zade R, Dudkina O, Tychkova V, et al.. Evaluation of the performance of SARS-CoV-2 antibody assays for a longitudinal population-based study of COVID-19 spread in St. Petersburg, Russia. J Med Virol. 2021;93(10):5846–5852. doi: 10.1002/jmv.27126</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27126</ArticleId><ArticleId IdType="pmc">PMC8242745</ArticleId><ArticleId IdType="pubmed">34081328</ArticleId></ArticleIdList></Reference><Reference><Citation>Decree of the Arkhangelsk Governor March 17, 2020. No. 28-u. “On the set of restrictive and other measures to counteract the spread of new coronavirus infection (COVID-19) in the Arkhangelsk Region”.</Citation></Reference><Reference><Citation>"On the State of Sanitary and Epidemiological Well-being of the Population in the Arkhangelsk Region in 2021: State Report / Edited by T.I. Nosovsky–Arkhangelsk, 2022.– 146 p."</Citation></Reference><Reference><Citation>Barchuk A, Skougarevskiy D, Kouprianov A, Shirokov D, Dudkina O, Tursun-Zade R, et al.. COVID-19 pandemic in Saint Petersburg, Russia: Combining population-based serological study and surveillance data. PloS one. 2022;17(6):e0266945. doi: 10.1371/journal.pone.0266945</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0266945</ArticleId><ArticleId IdType="pmc">PMC9200332</ArticleId><ArticleId IdType="pubmed">35704649</ArticleId></ArticleIdList></Reference><Reference><Citation>Popova AY, Smirnov VS, Andreeva EE, Babura EA, Balakhonov SV, Bashketova NS, et al.. SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic. Viruses. 2021;13(8). doi: 10.3390/v13081648</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13081648</ArticleId><ArticleId IdType="pmc">PMC8402751</ArticleId><ArticleId IdType="pubmed">34452512</ArticleId></ArticleIdList></Reference><Reference><Citation>Accorsi E.K., Qiu X., Rumpler E. et al.. How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19. Eur J Epidemiol. 2021; 36: 179–196. doi: 10.1007/s10654-021-00727-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-021-00727-7</ArticleId><ArticleId IdType="pmc">PMC7906244</ArticleId><ArticleId IdType="pubmed">33634345</ArticleId></ArticleIdList></Reference><Reference><Citation>Menachemi N, Dixon BE, Wools-Kaloustian KK, Yiannoutsos CT, Halverson PK. How Many SARS-CoV-2-Infected People Require Hospitalization? Using Random Sample Testing to Better Inform Preparedness Efforts. Journal of public health management and practice: JPHMP. 2021;27(3):246–50. doi: 10.1097/PHH.0000000000001331</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHH.0000000000001331</ArticleId><ArticleId IdType="pubmed">33729203</ArticleId></ArticleIdList></Reference><Reference><Citation>Hozé N, Paireau J, Lapidus N, Tran Kiem C, Salje H, Severi G, et al.. Monitoring the proportion of the population infected by SARS-CoV-2 using age-stratified hospitalisation and serological data: a modelling study. Lancet Public Health. 2021;6(6):e408–e415. doi: 10.1016/S2468-2667(21)00064-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(21)00064-5</ArticleId><ArticleId IdType="pmc">PMC8032222</ArticleId><ArticleId IdType="pubmed">33838700</ArticleId></ArticleIdList></Reference><Reference><Citation>Malundo AFG, Abad CLR, Salamat MSS, Sandejas JCM, Planta JEG, Poblete JB, et al.. Clinical characteristics of patients with asymptomatic and symptomatic COVID-19 admitted to a tertiary referral centre in the Philippines. IJID regions. 2022;2:204–211. doi: 10.1016/j.ijregi.2022.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijregi.2022.02.002</ArticleId><ArticleId IdType="pmc">PMC8818128</ArticleId><ArticleId IdType="pubmed">35721425</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti P, Younes A. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. JBRHA. 2020;34(2):339–343. doi: 10.23812/Editorial-Conti-3</Citation><ArticleIdList><ArticleId IdType="doi">10.23812/Editorial-Conti-3</ArticleId><ArticleId IdType="pubmed">32253888</ArticleId></ArticleIdList></Reference><Reference><Citation>Abate BB, Kassie AM, Kassaw MW, Aragie TG, Masresha SA. Sex difference in coronavirus disease (COVID-19): a systematic review and meta-analysis. BMJ open. 2020;10(10):e040129. doi: 10.1136/bmjopen-2020-040129</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-040129</ArticleId><ArticleId IdType="pmc">PMC7539579</ArticleId><ArticleId IdType="pubmed">33028563</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, et al.. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front Public Health. 2020;8:152. doi: 10.3389/fpubh.2020.00152</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00152</ArticleId><ArticleId IdType="pmc">PMC7201103</ArticleId><ArticleId IdType="pubmed">32411652</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Shi J, Xia J, Duan J, Chen L, Yu X, et al.. Asymptomatic and Symptomatic Patients With Non-severe Coronavirus Disease (COVID-19) Have Similar Clinical Features and Virological Courses: A Retrospective Single Center Study. Front Microbiol. 2020;11:1570. doi: 10.3389/fmicb.2020.01570</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.01570</ArticleId><ArticleId IdType="pmc">PMC7344298</ArticleId><ArticleId IdType="pubmed">32754137</ArticleId></ArticleIdList></Reference><Reference><Citation>Singhal S, Kumar P, Singh S, Saha S, Dey AB. Clinical features and outcomes of COVID-19 in older adults: a systematic review and meta-analysis. BMC geriatrics. 2021;21(1):321. doi: 10.1186/s12877-021-02261-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-021-02261-3</ArticleId><ArticleId IdType="pmc">PMC8133052</ArticleId><ArticleId IdType="pubmed">34011269</ArticleId></ArticleIdList></Reference><Reference><Citation>Mal P, Mukherjee T, Upadhyay AK, Mohanty S, Pattnaik AK. Connecting the dots between inflammatory cascades of obesity and COVID-19 in light of mortal consequences-a review. Environ Sci Pollut Res Int. 2022;29(38):57040–53. doi: 10.1007/s11356-022-21461-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11356-022-21461-x</ArticleId><ArticleId IdType="pmc">PMC9213647</ArticleId><ArticleId IdType="pubmed">35731430</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen A, Bressem K, Albrecht J, Thieß HM, Vahldiek J, Hamm B, et al.. The role of visceral adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectional pilot study in Germany. Metabolism. 2020;110:154317. doi: 10.1016/j.metabol.2020.154317</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154317</ArticleId><ArticleId IdType="pmc">PMC7358176</ArticleId><ArticleId IdType="pubmed">32673651</ArticleId></ArticleIdList></Reference><Reference><Citation>Mubarik S, Liu X, Eshak ES, Liu K, Liu Q, Wang F, et al.. The Association of Hypertension With the Severity of and Mortality From the COVID-19 in the Early Stage of the Epidemic in Wuhan, China: A Multicenter Retrospective Cohort Study. Front Med. 2021; 8: 623608. doi: 10.1016/j.metabol.2020.154317</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154317</ArticleId><ArticleId IdType="pmc">PMC8149896</ArticleId><ArticleId IdType="pubmed">34055822</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim GU, Kim MJ, Ra SH, Lee J, Bae S, Jung J, et al.. Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19. Clin Microbiol Infect. 2020;26(7):948.e1-.e3. doi: 10.1016/j.cmi.2020.04.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.04.040</ArticleId><ArticleId IdType="pmc">PMC7252018</ArticleId><ArticleId IdType="pubmed">32360780</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzatenta A, Neri G, D’Ardes D, De Luca C, Marinari S, Porreca E, et al.. Smell and Taste in Severe CoViD-19: Self-Reported vs. Testing. Front Med. 2020;7:589409. doi: 10.3389/fmed.2020.589409</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.589409</ArticleId><ArticleId IdType="pmc">PMC7745760</ArticleId><ArticleId IdType="pubmed">33344476</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahey GM, Marshall KE, McDonald E, Martin SW, Tate JE, Midgley CM, et al.. Symptom Profiles and Progression in Hospitalized and Nonhospitalized Patients with Coronavirus Disease, Colorado, USA, 2020. Emerg Infect Dis. 2021;27(2):385–395. doi: 10.3201/eid2702.203729</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2702.203729</ArticleId><ArticleId IdType="pmc">PMC7853576</ArticleId><ArticleId IdType="pubmed">33496225</ArticleId></ArticleIdList></Reference><Reference><Citation>Schäfer E, Scheer C, Saljé K, Fritz A, Kohlmann T, Hübner NO, et al.. Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection. Sci Rep. 2022;12(1):7249. doi: 10.1038/s41598-022-11103-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-11103-0</ArticleId><ArticleId IdType="pmc">PMC9065670</ArticleId><ArticleId IdType="pubmed">35508524</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Q, Liu J, Liu Q, Kang L, Liu R, Jing W, et al.. Global Percentage of Asymptomatic SARS-CoV-2 Infections Among the Tested Population and Individuals With Confirmed COVID-19 Diagnosis: A Systematic Review and Meta-analysis. JAMA network open. 2021;4(12):e2137257-e. doi: 10.1001/jamanetworkopen.2021.37257</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.37257</ArticleId><ArticleId IdType="pmc">PMC8672238</ArticleId><ArticleId IdType="pubmed">34905008</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Andraweera P, Elliott S, Mohammed H, Lassi Z, Twigger A, et al.. Asymptomatic SARS-CoV-2 infection by age: A systematic review and meta-analysis. Pediatr Infect Dis J. 2023; 42(3):232–239. doi: 10.1097/INF.0000000000003791</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003791</ArticleId><ArticleId IdType="pmc">PMC9935239</ArticleId><ArticleId IdType="pubmed">36730054</ArticleId></ArticleIdList></Reference><Reference><Citation>Struyf T, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, et al.., Cochrane COVID-19 Diagnostic Test Accuracy Group. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19. Cochrane Database Syst Rev 2022, 5: CD013665. doi: 10.1002/14651858.CD013665.pub3</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013665.pub3</ArticleId><ArticleId IdType="pmc">PMC9121352</ArticleId><ArticleId IdType="pubmed">35593186</ArticleId></ArticleIdList></Reference><Reference><Citation>Methi F, Madslien EH. Lower transmissibility of SARS-CoV-2 among asymptomatic cases: evidence from contact tracing data in Oslo, Norway. BMC medicine. 2022;20(1):427. doi: 10.1186/s12916-022-02642-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02642-4</ArticleId><ArticleId IdType="pmc">PMC9641677</ArticleId><ArticleId IdType="pubmed">36348327</ArticleId></ArticleIdList></Reference><Reference><Citation>Vachon CM, Norman AD, Prasad K, Jensen D, Schaeferle GM, Vierling KL, et al.. Rates of Asymptomatic COVID-19 Infection and Associated Factors in Olmsted County, Minnesota, in the Prevaccination Era. Mayo Clinic proceedings Innovations, quality &amp; outcomes. 2022;6(6):605–617. doi: 10.1016/j.mayocpiqo.2022.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocpiqo.2022.10.001</ArticleId><ArticleId IdType="pmc">PMC9578336</ArticleId><ArticleId IdType="pubmed">36277251</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto Saravia V. Sociodemographic Differences in COVID-19 Self-Reported Symptoms by Ethnicity and Older Adults in Bolivia. Journal of population ageing. 2022;15(3):811–41. doi: 10.1007/s12062-022-09383-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12062-022-09383-5</ArticleId><ArticleId IdType="pmc">PMC9358097</ArticleId><ArticleId IdType="pubmed">35965641</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyara M, Tubach F, Pourcher V, Morélot-Panzini C, Pernet J, Haroche J, et al.. Lower Rate of Daily Smokers With Symptomatic COVID-19: A Monocentric Self-Report of Smoking Habit Study. Front Med. 2021;8:668995. doi: 10.3389/fmed.2021.668995</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.668995</ArticleId><ArticleId IdType="pmc">PMC8766759</ArticleId><ArticleId IdType="pubmed">35071251</ArticleId></ArticleIdList></Reference><Reference><Citation>Saurabh S, Verma MK, Gautam V, Kumar N, Jain V, Goel AD, et al.. Tobacco, alcohol use and other risk factors for developing symptomatic COVID-19 vs asymptomatic SARS-CoV-2 infection: a case-control study from western Rajasthan, India. Trans R Soc Trop Med Hyg. 2021;115(7):820–831. doi: 10.1093/trstmh/traa172</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/trstmh/traa172</ArticleId><ArticleId IdType="pmc">PMC7928693</ArticleId><ArticleId IdType="pubmed">33444432</ArticleId></ArticleIdList></Reference><Reference><Citation>Naimeh M, Afsaneh A, Zahra A, Ali D, Abdullah B, Marzieh RR. Smoking as a Risk or Protective Factor in Developing and Severity of COVID-19? J Acute Med. 2023;13(3):114–121. doi: 10.6705/j.jacme.202309_13(3).0003</Citation><ArticleIdList><ArticleId IdType="doi">10.6705/j.jacme.202309_13(3).0003</ArticleId><ArticleId IdType="pmc">PMC10568632</ArticleId><ArticleId IdType="pubmed">37841826</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallus S, Scala M, Possenti I, Jarach CM, Clancy L, Fernandez E, et al.. The role of smoking in COVID-19 progression: a comprehensive meta-analysis. Eur Respir Rev. 2023;32(167):220191. doi: 10.1183/16000617.0191-2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0191-2022</ArticleId><ArticleId IdType="pmc">PMC10032583</ArticleId><ArticleId IdType="pubmed">36889786</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson SE, Tattan-Birch H, Shahab L, Beard E, Brown J. Have there been sustained impacts of the COVID-19 pandemic on trends in smoking prevalence, uptake, quitting, use of treatment, and relapse? A monthly population study in England, 2017–2022. BMC Medicine. 2023;21(1):474. doi: 10.1186/s12916-023-03157-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-023-03157-2</ArticleId><ArticleId IdType="pmc">PMC10720231</ArticleId><ArticleId IdType="pubmed">38093317</ArticleId></ArticleIdList></Reference><Reference><Citation>Farsalinos K, Barbouni A, Niaura R. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Intern Emerg Med 2020;15:845–852. doi: 10.1007/s11739-020-02355-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-020-02355-7</ArticleId><ArticleId IdType="pmc">PMC7210099</ArticleId><ArticleId IdType="pubmed">32385628</ArticleId></ArticleIdList></Reference><Reference><Citation>Latkin C.A.; Edwards C.; Davey-Rothwell M.A.; Tobin K.E. The relationship between social desirability bias and self-reports of health, substance use, and social network factors among urban substance users in Baltimore, Maryland. Addict Behav. 2017; 73: 133–136. doi: 10.1016/j.addbeh.2017.05.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addbeh.2017.05.005</ArticleId><ArticleId IdType="pmc">PMC5519338</ArticleId><ArticleId IdType="pubmed">28511097</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Sun J. The impact of current smoking, regular drinking, and physical inactivity on health care-seeking behavior in China. BMC health services research. 2022;22(1):52. doi: 10.1186/s12913-022-07462-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-022-07462-z</ArticleId><ArticleId IdType="pmc">PMC8751354</ArticleId><ArticleId IdType="pubmed">35012543</ArticleId></ArticleIdList></Reference><Reference><Citation>Salerno S, Zhao Z, Prabhu Sankar S, Salvatore M, Gu T, Fritsche LG, et al.. Patterns of repeated diagnostic testing for COVID-19 in relation to patient characteristics and outcomes. J Intern Med. 2021;289(5):726–737. doi: 10.1111/joim.13213</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13213</ArticleId><ArticleId IdType="pmc">PMC7753604</ArticleId><ArticleId IdType="pubmed">33253457</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Ma S, Han T, Qu G, Cheng C, Uy JP, et al.. Association of smoking history with severe and critical outcomes in COVID-19 patients: A systemic review and meta-analysis. European journal of integrative medicine. 2021;43:101313. doi: 10.1016/j.eujim.2021.101313</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eujim.2021.101313</ArticleId><ArticleId IdType="pmc">PMC7889467</ArticleId><ArticleId IdType="pubmed">33619437</ArticleId></ArticleIdList></Reference><Reference><Citation>Gülsen A, Yigitbas BA, Uslu B, Drömann D, Kilinc O. The Effect of Smoking on COVID-19 Symptom Severity: Systematic Review and Meta-Analysis. Pulm Med. 2020;2020:7590207. doi: 10.1155/2020/7590207</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/7590207</ArticleId><ArticleId IdType="pmc">PMC7499286</ArticleId><ArticleId IdType="pubmed">32963831</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy RK, Charles WN, Sklavounos A, Dutt A, Seed PT, Khajuria A. The effect of smoking on COVID-19 severity: A systematic review and meta-analysis. J Med Virol. 2021;93(2):1045–1056. doi: 10.1002/jmv.26389</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26389</ArticleId><ArticleId IdType="pmc">PMC7436545</ArticleId><ArticleId IdType="pubmed">32749705</ArticleId></ArticleIdList></Reference><Reference><Citation>Changeux JP, Amoura Z, Rey FA, Miyara M. A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications. C R biol. 2020;343(1):33–39. doi: 10.5802/crbiol.8</Citation><ArticleIdList><ArticleId IdType="doi">10.5802/crbiol.8</ArticleId><ArticleId IdType="pubmed">32720486</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Tao ZW, Wang L, Yuan ML, Liu K, Zhou L, et al.. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J. 2020;133(9):1032–1038. doi: 10.1097/CM9.0000000000000775</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CM9.0000000000000775</ArticleId><ArticleId IdType="pmc">PMC7147279</ArticleId><ArticleId IdType="pubmed">32118640</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanimoto K, Hirota K, Fukazawa T, Matsuo Y, Nomura T, Tanuza N, et al.. Inhibiting SARS-CoV-2 infection in vitro by suppressing its receptor, angiotensin-converting enzyme 2, via aryl-hydrocarbon receptor signal. Sci Rep‥ 2021;11(1):16629. doi: 10.1038/s41598-021-96109-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-96109-w</ArticleId><ArticleId IdType="pmc">PMC8371152</ArticleId><ArticleId IdType="pubmed">34404832</ArticleId></ArticleIdList></Reference><Reference><Citation>Krieger E, Kudryavtsev A, Sharashova E, Postoev V, Belova N, Shagrov L, et al.. Seroprevalence of SARS-Cov-2 Antibodies in Adults, Arkhangelsk, Russia. Emerg Infect Dis. 2022;28(2):463–465. doi: 10.3201/eid2802.211640</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2802.211640</ArticleId><ArticleId IdType="pmc">PMC8798687</ArticleId><ArticleId IdType="pubmed">35076366</ArticleId></ArticleIdList></Reference><Reference><Citation>Binkheder S, Asiri MA, Altowayan KW, Alshehri TM, Alzarie MF, Aldekhyyel RN, et al.. Real-World Evidence of COVID-19 Patients’ Data Quality in the Electronic Health Records. Healthcare (Basel, Switzerland). 2021;9(12). doi: 10.3390/healthcare9121648</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare9121648</ArticleId><ArticleId IdType="pmc">PMC8701465</ArticleId><ArticleId IdType="pubmed">34946374</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang C, Yao X, Zhao Y, Wu J, Huang P, Pan C, et al.. Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season. Microbes Infect. 2020;22(6–7):236–244. doi: 10.1016/j.micinf.2020.05.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2020.05.005</ArticleId><ArticleId IdType="pmc">PMC7217786</ArticleId><ArticleId IdType="pubmed">32405236</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bert N, Tan AT, Kunasegaran K, Tham CYL, Hafezi M, Chia A, et al.. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. 2020;584(7821):457–62. doi: 10.1038/s41586-020-2550-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2550-z</ArticleId><ArticleId IdType="pubmed">32668444</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Guo M, Wu F, Xiong N, Ma Y, Wang Z, et al.. Factors associated with asymptomatic infection in health-care workers with severe acute respiratory syndrome coronavirus 2 infection in Wuhan, China: a multicentre retrospective cohort study. Clin Microbiol Infect. 2020;26(12):1670–1675. doi: 10.1016/j.cmi.2020.08.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.08.038</ArticleId><ArticleId IdType="pmc">PMC7476563</ArticleId><ArticleId IdType="pubmed">32911080</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G, Li W, He X, Cao Y. Asymptomatic and Presymptomatic Infectors: Hidden Sources of Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2020;71(8):2018. doi: 10.1093/cid/ciaa418</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa418</ArticleId><ArticleId IdType="pmc">PMC7184467</ArticleId><ArticleId IdType="pubmed">32271372</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>